Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.72%22.15B | 13.48%88.97B | 32.19%21.36B | -2.42%78.4B | 0.19%21.91B | 1.29%19.84B | 8.95%20.49B | -19.54%16.16B | 44.74%80.35B | 46.60%21.87B |
| Cost of revenue | 6.27%18.52B | 15.59%72.92B | 31.59%17.43B | 6.88%63.09B | 7.21%17.51B | 5.34%15.89B | 25.26%16.45B | -8.55%13.24B | 41.37%59.03B | 46.48%16.33B |
| Gross profit | -7.61%3.63B | 4.81%16.05B | 34.92%3.93B | -28.17%15.32B | -20.50%4.41B | -12.28%3.95B | -28.73%4.05B | -47.98%2.91B | 54.96%21.32B | 46.94%5.54B |
| Operating expense | 12.36%2.81B | 5.01%10.17B | 11.86%2.5B | -8.86%9.69B | 6.88%2.66B | -10.31%2.41B | -3.83%2.39B | -24.91%2.23B | 24.59%10.63B | -1.50%2.49B |
| Operating profit | -42.52%822M | 4.46%5.88B | 110.91%1.43B | -47.36%5.63B | -42.80%1.75B | -15.20%1.54B | -48.02%1.66B | -74.15%678M | 104.51%10.69B | 145.10%3.05B |
| Net non-operating interest income (expenses) | -52.11%-108M | -50.23%-329M | -47.92%-71M | -25.86%-219M | -27.08%-61M | -30.23%-56M | -31.71%-54M | -14.29%-48M | 0.57%-174M | -14.29%-48M |
| Non-operating interest income | --0 | --0 | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Non-operating interest expense | 52.11%108M | 50.23%329M | 47.92%71M | 25.86%219M | 27.08%61M | 30.23%56M | 31.71%54M | 14.29%48M | -0.57%174M | 14.29%48M |
| Net investment income | -160.89%-313M | -114.78%-120M | -14.19%514M | 620.51%812M | 1,837.93%504M | 17.90%-619M | 19.71%328M | 69.69%599M | -273.33%-156M | -127.88%-29M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 6M | ||||||||
| Income from associates and other participating interests | 160.00%13M | 38.89%25M | 25.00%5M | 5.88%18M | -11.11%8M | -33.33%2M | -20.00%4M | 4M | 6.25%17M | -10.00%9M |
| Special income (charges) | 141.67%25M | -8,750.00%-177M | -500.00%-60M | 98.43%-2M | 130.00%6M | 73.39%-33M | 775.00%35M | -176.92%-10M | 18.59%-127M | 82.46%-20M |
| Less:Other special charges | -141.67%-25M | 8,750.00%177M | 500.00%60M | -98.43%2M | -130.00%-6M | -73.39%33M | -775.00%-35M | 176.92%10M | -18.59%127M | -82.46%20M |
| Other non-operating income (expenses) | -200.00%-21M | 212.77%53M | -121.88%-7M | -140.87%-47M | -111.41%-17M | 128.26%13M | -3,850.00%-75M | 220.00%32M | 818.75%115M | 14,800.00%149M |
| Income before tax | -76.86%419M | -13.87%5.33B | 44.19%1.81B | -40.31%6.19B | -29.90%2.19B | -0.47%847M | -44.81%1.9B | -57.51%1.26B | 107.96%10.37B | 159.14%3.12B |
| Income tax | -79.57%114M | 29.91%1.61B | 83.55%558M | -56.87%1.24B | -71.81%278M | 1,387.50%238M | -55.16%417M | -67.52%304M | 122.67%2.87B | 395.48%986M |
| Net income | -75.72%304M | -24.79%3.73B | 31.65%1.25B | -33.99%4.95B | -10.59%1.91B | -26.95%610M | -40.98%1.49B | -52.92%951M | 102.89%7.51B | 112.34%2.13B |
| Net income continuous operations | -75.66%305M | -24.80%3.73B | 31.62%1.25B | -33.98%4.96B | -10.54%1.91B | -27.07%609M | -40.98%1.49B | -52.87%952M | 102.84%7.51B | 112.34%2.13B |
| Noncontrolling interests | 0 | 2M | 100.00%2M | 0 | 2M | -2M | 0 | -50.00%1M | ||
| Net income attributable to the company | -75.72%304M | -24.74%3.73B | 31.37%1.25B | -34.02%4.95B | -10.60%1.91B | -27.15%609M | -41.08%1.48B | -52.80%953M | 103.09%7.5B | 112.77%2.13B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -75.72%304M | -24.74%3.73B | 31.37%1.25B | -34.02%4.95B | -10.60%1.91B | -27.15%609M | -41.08%1.48B | -52.80%953M | 103.09%7.5B | 112.77%2.13B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -75.73%4.2713 | -24.74%52.36 | 31.44%17.6 | -34.02%69.57 | -10.61%26.78 | -27.17%8.55 | -41.04%20.85 | -52.82%13.39 | 103.04%105.44 | 112.63%29.96 |
| Diluted earnings per share | -75.73%4.2713 | -24.74%52.36 | 31.44%17.6 | -34.02%69.57 | -10.60%26.78 | -27.17%8.55 | -41.07%20.8368 | -52.82%13.39 | 103.04%105.44 | 112.78%29.9555 |
| Dividend per share | 0 | -14.29%18 | 0 | -30.00%21 | -21.05%15 | 0 | -45.45%6 | 0 | 100.00%30 | 111.11%19 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |